GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

GemVax&KAEL Revenue

In the year 2025, GemVax&KAEL had annual revenue of 81.53B KRW with 30.05% growth. GemVax&KAEL had revenue of 26.16B in the quarter ending December 31, 2025, with 43.18% growth.

• Revenue: 81.53B
• Revenue Growth: +30.05%
• P/S Ratio: 12.83
• Revenue / Employee: 447.97M
• Employees: 182
• Market Cap: 1.05T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	81.53B	18.84B	30.05%
Dec 31, 2024	62.69B	-9.52B	-13.18%
Dec 31, 2023	72.21B	-3.60B	-4.74%
Dec 31, 2022	75.80B	15.43B	25.56%
Dec 31, 2021	60.37B	-5.29B	-8.06%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error